Article · 11 min read · Written by Dr. Lisa L. Johnson, M.D.
Sacral Neuromodulation for Fecal Incontinence
Learn how sacral neuromodulation for fecal incontinence works, who may be considered, what the trial involves, and how it compares with other treatment options.
Accidental bowel leakage can affect daily routines, travel, intimacy, and confidence, but it is not something you have to accept as a normal part of aging. The right treatment depends on the pattern of symptoms, their underlying cause, and how you respond to conservative care.
Sacral neuromodulation for fecal incontinence uses a small device to send mild electrical impulses to nerves involved in bowel control. A temporary trial helps show whether the therapy may reduce leakage before a permanent neurostimulator is considered.
This therapy is one option within a broader, step-by-step plan. Understanding how it works, who may be considered, and what the trial involves can help you have a more informed conversation about your care.
Request a Consultation with Dr. Johnson
What Is Sacral Neuromodulation for Fecal Incontinence?
Sacral neuromodulation is a treatment that uses mild electrical impulses to help regulate the nerves involved in bowel control. A small implanted device, sometimes discussed by its brand name, InterStim, sends these signals to the sacral nerves near the lower spine. These nerves help coordinate communication between the brain, bowel, rectum, and muscles that support continence. The goal is to improve that communication and reduce episodes of accidental bowel leakage for appropriately selected patients.
This is not a cure that repairs every possible cause of fecal incontinence, and it is not the right choice for everyone. Fecal incontinence can occur in urge, passive, or mixed patterns. Urge leakage may happen when a person cannot reach the bathroom in time. Passive leakage may occur without a clear sensation of stool or gas passing. Mixed symptoms combine elements of both. Understanding the pattern and identifying contributing conditions are important before discussing an advanced treatment.
Pelvic Health Institute of Illinois lists sacral neuromodulation among advanced treatment options for fecal incontinence. The practice also approaches pelvic health as an interconnected system, because bowel symptoms may overlap with other pelvic floor or bladder concerns. Treatment planning should begin with an evaluation of the symptoms and their likely cause, followed by appropriate non-surgical options when they may help.
This focused procedure guide explains how sacral neuromodulation works and how clinicians may evaluate whether it is appropriate. It is different from a general overview of fecal incontinence treatment options, which covers the condition more broadly. Learning about the device does not mean that an implant is automatically recommended. The next question is whether a person's symptoms, evaluation findings, and response to earlier care support considering a trial.
Who May Be a Candidate for Sacral Neuromodulation?
Sacral neuromodulation is not automatically the next step for everyone with accidental bowel leakage. It may be considered when fecal incontinence continues despite appropriate conservative treatment. But the decision depends on the pattern of symptoms, the suspected cause, overall health, and what matters most in daily life. A careful evaluation helps distinguish urgency, passive leakage, and mixed symptoms, while also looking for bowel conditions that may be causing or worsening leakage.
Underlying causes can vary. Some people have symptoms without a clearly identified structural injury, while others may have an external anal sphincter defect or another problem affecting bowel control. Fecal incontinence can also occur alongside chronic constipation, which means treatment may need to address stool consistency, emptying, and bowel habits before an advanced procedure is considered. Treating the contributing problem may improve control without an implant.
Conservative-first care commonly includes behavioral and dietary changes, bowel-regimen adjustments when appropriate, and other non-surgical strategies selected for the individual. In a review of sacral neuromodulation, the therapy was discussed for adults with chronic symptoms that had not responded adequately to first-line treatment. A separate prospective study focused on selected patients with idiopathic symptoms or a limited external anal sphincter defect after maximal conservative therapy. These study populations describe research selection criteria, not a universal rule for every patient.
For that reason, candidacy is a shared decision rather than a checklist. Your clinician may discuss how often leakage occurs, whether you can sense the urge to have a bowel movement. Stool consistency, constipation or urgency, prior treatments, and how symptoms affect work, travel, sleep, and relationships. Keeping a simple record of episodes and triggers can make that conversation more useful, but it does not determine candidacy by itself.
People considering evaluation may also benefit from reading about what to expect from anorectal care. A consultation can clarify whether sacral neuromodulation fits your situation, whether another treatment deserves attention first, and what questions to ask before deciding.
What Happens During the Trial and Permanent Implant?
Sacral neuromodulation is usually approached in stages. The purpose is to understand how your symptoms respond before deciding whether a permanent neurostimulator belongs in your treatment plan. The exact pathway depends on your evaluation, medical history, symptoms, and response during testing.
Evaluation and treatment planning
Your clinician first reviews your accidental bowel leakage pattern, medical history, prior treatments, and goals. This evaluation helps identify possible causes and determine whether sacral neuromodulation is appropriate. At Pelvic Health Institute of Illinois, the treatment is considered within a conservative-first plan, rather than as an automatic next step for everyone.
A temporary lead is placed for testing
If testing is appropriate, a temporary lead is used to deliver stimulation to the sacral nerves involved in bowel control. PHII describes this temporary-lead test as part of the treatment pathway. The lead connects to an external neurostimulator that can be worn on a belt under clothing, according to the Cleveland Clinic guide. This staged approach lets you experience the therapy before a permanent device is considered.
You track symptoms during the evaluation phase
During the trial, you may be asked to record leakage episodes and other relevant bowel symptoms. A symptom record gives you and your clinician a clearer basis for discussing whether meaningful change occurred in daily life. The Cleveland Clinic guide describes an evaluation phase lasting 7 to 14 days. That is the duration described in that guide, not a universal promise or fixed PHII schedule.
You and your clinician review the response
At the end of testing, the results are reviewed together. The decision is based on your symptoms, your experience with the temporary stimulation, and the overall clinical picture. A helpful response does not mean that every symptom must disappear, and a limited response does not represent a personal failure. It may simply show that another treatment approach deserves attention.
A permanent neurostimulator may be considered
If the trial supports moving forward, the next stage is placement of a permanent neurostimulator. Medical reviews describe this as a staged pathway, with the temporary evaluation preceding the permanent implant. Follow-up remains important after implantation so your clinician can assess symptom patterns, answer questions, and guide ongoing care. Ask what to expect at each visit, and share any changes or concerns rather than trying to manage them alone.
This step-by-step process is designed to support an informed decision. Sacral neuromodulation can be discussed alongside other options when conservative measures have not provided enough relief and the evaluation supports considering advanced treatment.
What Results Can Patients Expect Long Term?
Results are usually assessed by looking at more than whether leakage stopped on one particular day. A bowel diary can help track the number of episodes, urgency, stool consistency, triggers, and how symptoms affect daily activities. This record gives you and your clinician a clearer way to discuss changes over time instead of relying only on memory. It can also show whether symptoms are changing for reasons that may need separate attention.
Research can help explain what has been observed, but it cannot predict exactly what will happen for one person. In one prospective study of 73 selected patients, 92% had at least a 50% reduction in fecal-incontinence episodes 24 weeks after a one-stage implant. In that same study, median episodes decreased from 13 at baseline to 2 at 24 weeks, and researchers reported improvements in quality-of-life measures and patient satisfaction. These were findings from a specific study group and a 24-week follow-up period. They are not a guarantee, a universal outcome, or a result from Pelvic Health Institute of Illinois. Read the study details and its selected-patient criteria.
Long-term care also includes recognizing the limits of the treatment. Sacral neuromodulation may reduce accidental bowel leakage without correcting every factor that contributes to it. Constipation, loose stool, changes in diet, medication effects, pelvic floor or anal muscle concerns, and other bowel conditions can influence symptoms. If episodes return, change pattern, or begin affecting your quality of life again, reassessment can help determine what is contributing and whether the treatment plan should change.
Follow-up is individualized rather than based on one schedule that fits everyone. Your clinician may review your diary, symptoms, bowel habits, and daily function, then discuss next steps with you. The goal is not simply to pursue a device. It is to build a realistic plan for safer, more predictable bowel control while continuing to address the whole picture of your pelvic health.
How Does It Compare With Biofeedback, Bowel Care, and Surgery?
There is no single best treatment for accidental bowel leakage. The right choice depends on the cause, symptom pattern, severity, and how you respond to earlier care. A conservative-first plan does not mean ignoring persistent symptoms. It means starting with options that address bowel habits and function, then considering an implanted therapy or surgery when the clinical situation supports it.
| Approach | Its role | When it may be considered | Important decision factors |
|---|---|---|---|
| Dietary and bowel care | Helps manage stool consistency, urgency, constipation, and other factors that can trigger or worsen leakage. | Usually part of the first treatment steps, whether symptoms are occasional or persistent. | Food patterns, stool frequency, constipation, medications, and the cause of symptoms all matter. Fiber or a bowel regimen should be individualized. |
| Biofeedback | Uses guided feedback to help a person understand and coordinate bowel-control muscles and sensations. | May be considered when improving awareness and muscle control could help, especially after evaluation identifies a functional component. | Progress depends on the underlying problem, ability to participate, and measurable changes in symptoms. It is not the same as an implanted device. |
| Sacral neuromodulation | Uses mild electrical stimulation from an implanted system to influence nerves involved in bowel control. | May be considered when appropriate conservative treatments have not controlled symptoms and evaluation supports this option. A temporary test can help inform the decision. | It involves a procedure and ongoing follow-up. The expected benefits, limitations, and alternatives should be discussed for the individual case. |
| Surgery | Addresses a specific structural problem or another condition when repair or a different operation is medically appropriate. | Considered selectively after the cause has been evaluated, particularly when a structural issue requires a surgical approach. | The operation, recovery, risks, and likelihood of helping depend on the anatomy and diagnosis. Surgery is not automatically the next step after conservative care. |
These options can overlap rather than follow a rigid ladder. For example, a person may need bowel management while the clinician evaluates muscle, nerve, or structural factors. The review of fecal incontinence and hemorrhoids also explains why more than one anorectal concern may need attention.
Evidence reviews describe dietary changes, bowel strategies, and biofeedback among first therapeutic steps, while sacral neuromodulation is generally reserved for selected patients whose symptoms remain difficult to control. Pelvic Health Institute of Illinois prioritizes non-surgical options before procedures and surgery when appropriate. A careful evaluation helps match treatment to the actual cause rather than choosing an advanced option based only on symptom severity.
I am not sure what is wrong. Help me understand my options.
Frequently Asked Questions
Who may be considered for sacral neuromodulation?
Candidacy depends on the cause and pattern of accidental bowel leakage, your overall health, and how symptoms respond to conservative care. A clinician may consider this treatment when dietary changes, bowel routines, medication, or other appropriate options have not provided enough control. Evaluation is individualized because fecal incontinence can occur alongside constipation or other pelvic-floor conditions.
What happens during the sacral neuromodulation trial?
A temporary lead is placed near the sacral nerves and connected to a small external neurostimulator worn under clothing. You track symptoms during the evaluation period, which one clinical guide describes as 7 to 14 days. The response helps you and your clinician decide whether a permanent device is appropriate. (Cleveland Clinic)
How effective is sacral neuromodulation for fecal incontinence?
Results vary, and no treatment can promise the same outcome for every patient. In one study of selected patients, 92% had at least a 50% reduction in episodes at 24 weeks after implantation. That finding does not predict an individual result, so ongoing symptom tracking and follow-up remain important. (study report)
What are the disadvantages or limitations?
This is an implanted therapy that requires a procedure, a trial period, and follow-up. It may not control every episode, and the best choice depends on the underlying cause, prior treatments, and your goals. Alternatives may include dietary and behavioral changes, bowel-regimen adjustments, medication, biofeedback, or surgery when clinically appropriate.
Schedule a Conversation About Your Options
Fecal incontinence can affect daily routines, confidence, and comfort, but you do not have to sort through treatment choices alone. A thoughtful evaluation can help clarify what may be contributing to your symptoms and whether sacral neuromodulation may be appropriate for you. Request a Consultation with Pelvic Health Institute of Illinois to discuss your symptoms and possible next steps with Dr. Johnson.